Q3 2015 Holdings
Filed 2015-11-17 | 58 holdings | $47.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-11-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $38.8M | 368,775 | 82.0% |
| Cerus Corp(CERS) | COM | 157085101 | $7.3M | 1,603,427 | 15.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $116.6K | 8,332,930 | 0.2% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $88.1K | 957,634 | 0.2% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $80.9K | 17,750,510 | 0.2% |
| Medivation Inc | COM | 58501N101 | $74.5K | 1,752,642 | 0.2% |
| Incyte Corp(INCY) | COM | 45337C102 | $67.7K | 613,598 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA)A | ADR | 881624209 | $64.2K | 1,137,559 | 0.1% |
| Seattle Genetics IncA | COM | 812578102 | $53.6K | 1,390,173 | 0.1% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $53.0K | 1,322,592 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $51.0K | 1,562,587 | 0.1% |
| Rite AID CorpA | COM | 767754104 | $49.0K | 8,071,405 | 0.1% |
| Sage Therapeutics Inc(SG7)A | COM | 78667J108 | $48.4K | 1,142,864 | 0.1% |
| Wellcare Health Plans IncA | COM | 94946T106 | $44.3K | 514,273 | 0.1% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $40.8K | 1,067,978 | 0.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $40.5K | 747,460 | 0.1% |
| ZS Pharma IncA | COM | 98979G105 | $33.8K | 514,107 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $33.0K | 1,049,782 | 0.1% |
| Portola Pharmaceuticals IncA | COM | 737010108 | $32.8K | 769,641 | 0.1% |
| Neuroderm LTDA | ORD SHS | M74231107 | $30.2K | 1,462,699 | 0.1% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $22.2K | 1,385,641 | 0.0% |
| Celldex Therapeutics Inc New | COM | 15117B103 | $20.6K | 1,954,019 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $19.0K | 532,818 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $17.8K | 724,348 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $17.6K | 947,966 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $14.4K | 1,443,278 | 0.0% |
| Oxford Immunotec Global PLCA | ORD SHS | G6855A103 | $13.9K | 1,028,132 | 0.0% |
| Conformis Inc(CFMS) | COM | 20717E101 | $12.4K | 688,845 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $11.1K | 262,892 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $11.1K | 2,074,836 | 0.0% |
| Health NET Inc | COM | 42222G108 | $10.8K | 179,229 | 0.0% |
| Trinet Group Inc(TNET) | COM | 896288107 | $10.7K | 639,186 | 0.0% |
| Oncothyreon Inc | COM | 682324108 | $9.9K | 3,614,990 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $9.6K | 660,816 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.8K | 367,485 | 0.0% |
| Trivascular Technologies Inc | COM | 89685A102 | $7.3K | 1,463,983 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $7.2K | 514,300 | 0.0% |
| Avalanche Biotechnologies in | COM | 05337G107 | $6.2K | 748,420 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $6.1K | 277,000 | 0.0% |
| Durect Corp(DRRXEUR) | COM | 266605104 | $5.1K | 2,613,316 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $5.0K | 590,100 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $4.8K | 660,129 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $3.9K | $4,000,000 | 0.0% |
| Castlight Health Inc(CSLT1EUR) | CL B | 14862Q100 | $3.1K | 734,397 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $3.0K | 500,615 | 0.0% |
| Press Ganey Hldgs Inc | COM | 74113L102 | $2.5K | 84,966 | 0.0% |
| Eleven Biotherapeutics Inc | COM | 286221106 | $2.0K | 848,351 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $2.0K | 190,789 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.2K | 25,000 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $628 | 91,644 | 0.0% |